Tyra Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Tyra Biosciences Stock Summary

Tyra Biosciences competes with Connect Biopharma, RAPT Therapeutics, Xilio Development, Mineralys Therapeutics,, and Monte Rosa. Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California. Tyra Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people.

Tyra Biosciences Key Financial Ratios

Tyra Biosciences Key Balance Sheet Accounts

Tyra Biosciences Key Income Statement Accounts

Tyra Biosciences Key Cash Accounts

Tyra Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tyra Biosciences's current stock value. Our valuation model uses many indicators to compare Tyra Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tyra Biosciences competition to find correlations between indicators driving Tyra Biosciences's intrinsic value. More Info.Tyra Biosciences is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Tyra Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tyra Biosciences' earnings, one of the primary drivers of an investment's value.

Tyra Biosciences Systematic Risk

Today, most investors in Tyra Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tyra Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tyra Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Tyra Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tyra Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tyra Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Tyra Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tyra Biosciences's daily price indicators and compare them against related drivers.

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.